Foreign investors have been acquiring majority stakes in some of Vietnam's biggest pharmaceutical companies.

Drug companies should agree to "pay or play" in the urgent race to develop new antibiotics to tackle a global threat of antimicrobial resistance (AMR), according to a British government-commissioned review.